Airain Ltd’s Elevance Health ELV Stock Holding History

Airain Ltd’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$370K	Buy	+1,966	New	+$353K	0.02%	617
2016 Q3	–	Sell	-10,291	Closed	-$1.35M	–	658
2016 Q2	$1.35M	Sell	10,291 -7,923	-43%	-$1.08M	0.08%	271
2016 Q1	$2.53M	Buy	+18,214	New	+$2.43M	0.18%	139
2015 Q4	–	Sell	-2,738	Closed	-$383K	–	892
2015 Q3	$383K	Sell	2,738 -3,264	-54%	-$491K	0.02%	539
2015 Q2	$985K	Buy	+6,002	New	+$959K	0.06%	358
2013 Q4	–	Sell	-3,000	Closed	-$251K	–	604
2013 Q3	$251K	Buy	+3,000	New	+$257K	0.05%	356

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Airain Ltd's ELV Position: Q2 2017 in Review

Airain Ltd opened a new position in Elevance Health (ELV) in Q2 2017: 1,966 shares worth $370K. The stake represents 0.02% of the portfolio and ranks #617 among its holdings. This is a return to the name: Airain Ltd previously reported a position in ELV as recently as Q2 2016.

Airain Ltd first reported a position in ELV in Q3 2013 and has held it in 6 quarters since. The position peaked at $2.53M in Q1 2016. 851 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

Airain Ltd held 1,966 shares of Elevance Health worth $370K as of Q2 2017.
Elevance Health was a new Airain Ltd position in Q2 2017.
Elevance Health made up 0.02% of Airain Ltd's portfolio in Q2 2017, its #617 holding.
Airain Ltd first reported a position in Elevance Health in Q3 2013 and has held it in 6 quarters since.
Airain Ltd's Elevance Health position peaked at $2.53M in Q1 2016.
851 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.